JP2001507336A5 - - Google Patents

Download PDF

Info

Publication number
JP2001507336A5
JP2001507336A5 JP1998518975A JP51897598A JP2001507336A5 JP 2001507336 A5 JP2001507336 A5 JP 2001507336A5 JP 1998518975 A JP1998518975 A JP 1998518975A JP 51897598 A JP51897598 A JP 51897598A JP 2001507336 A5 JP2001507336 A5 JP 2001507336A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998518975A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001507336A (ja
JP4344014B2 (ja
Filing date
Publication date
Priority claimed from GBGB9622159.3A external-priority patent/GB9622159D0/en
Application filed filed Critical
Publication of JP2001507336A publication Critical patent/JP2001507336A/ja
Publication of JP2001507336A5 publication Critical patent/JP2001507336A5/ja
Application granted granted Critical
Publication of JP4344014B2 publication Critical patent/JP4344014B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP51897598A 1996-10-24 1997-10-23 粘膜性免疫用アジュバントとしてのポリアニオン性ポリマー Expired - Lifetime JP4344014B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9622159.3A GB9622159D0 (en) 1996-10-24 1996-10-24 Polyanionic polymers as adjuvants for mucosal immunization
GB9622159.3 1996-10-24
PCT/EP1997/005861 WO1998017310A2 (en) 1996-10-24 1997-10-23 Polyanionic polymers as adjuvants for mucosal immunization

Publications (3)

Publication Number Publication Date
JP2001507336A JP2001507336A (ja) 2001-06-05
JP2001507336A5 true JP2001507336A5 (https=) 2005-06-16
JP4344014B2 JP4344014B2 (ja) 2009-10-14

Family

ID=10801896

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51897598A Expired - Lifetime JP4344014B2 (ja) 1996-10-24 1997-10-23 粘膜性免疫用アジュバントとしてのポリアニオン性ポリマー

Country Status (11)

Country Link
US (1) US6610310B2 (https=)
EP (1) EP0934077B1 (https=)
JP (1) JP4344014B2 (https=)
AT (1) ATE360440T1 (https=)
AU (1) AU717349B2 (https=)
BR (1) BR9712436A (https=)
CA (1) CA2269780C (https=)
DE (1) DE69737658T2 (https=)
ES (1) ES2285741T3 (https=)
GB (1) GB9622159D0 (https=)
WO (1) WO1998017310A2 (https=)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050129680A1 (en) * 2001-09-17 2005-06-16 Paul Wentworth Antimicrobial activity of antibodies
US20040157280A1 (en) * 2001-09-17 2004-08-12 Paul Wentworth Antibody mediated ozone generation
US20040116350A1 (en) * 2001-09-17 2004-06-17 Paul Wentworth Jr Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
AU2003288058A1 (en) * 2002-11-14 2004-06-03 Novartis Ag Antibody- or neutrophil-mediated ozone generation
GB0313916D0 (en) * 2003-06-16 2003-07-23 Glaxosmithkline Biolog Sa Vaccine composition
JP4860109B2 (ja) * 2003-12-26 2012-01-25 バイオリーダース・コーポレイション ポリガンマグルタミン酸を含む免疫増強用組成物
DE102006047617B4 (de) * 2006-10-09 2008-11-27 Clariant International Limited Verfahren zur Herstellung basischer (Meth)acrylamide
US20090017064A1 (en) * 2007-07-10 2009-01-15 Wyeth Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
FR2922767B1 (fr) * 2007-10-24 2009-12-18 Seppic Sa Procede de preparation d'une composition vaccinale comprenant au moins un antigene et au moins un adjuvant.
UA98812C2 (ru) 2007-11-06 2012-06-25 Вайет Ллк Авирулентная активированная живая вакцина mycoplasma hyopneumoniae
EP2062594A1 (en) 2007-11-21 2009-05-27 Wyeth Farma, S.A. Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same
DE102008017216B4 (de) * 2008-04-04 2013-08-14 Clariant International Ltd. Kontinuierliches Verfahren zur Herstellung von Fettsäureamiden
TW201010719A (en) * 2008-08-19 2010-03-16 Wyeth Corp Immunological composition
GB0907989D0 (en) 2009-05-08 2009-06-24 Hybrid Systems Ltd Multivalent adjuvant display
SA110310528B1 (ar) 2009-06-22 2014-07-02 Wyeth Llc التركيبات المولدة للمناعة لأنتيجينات ستافيلوكوكس أوريس
SG10201406432RA (en) 2009-06-22 2014-11-27 Wyeth Llc Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
DE102009031059A1 (de) 2009-06-30 2011-01-05 Clariant International Ltd. Vorrichtung zur kontinuierlichen Durchführung chemischer Reaktionen bei hohen Temperaturen
US20110110980A1 (en) 2009-09-02 2011-05-12 Wyeth Llc Heterlogous prime-boost immunization regimen
DE102009042522A1 (de) 2009-09-22 2011-04-07 Clariant International Ltd. Kontinuierliches Umesterungsverfahren
DE102009042523B4 (de) 2009-09-22 2012-02-16 Clariant International Ltd. Vorrichtung und Verfahren zur kontinuierlichen Durchführung heterogen katalysierter chemischer Reaktionen bei hohen Temperaturen
WO2012017288A2 (en) 2010-08-04 2012-02-09 Carlo Ghisalberti Supramolecular complexes of polyanionic polymers and spermidine in tissue maintenance and repair
CN107913396B (zh) 2010-08-23 2022-03-08 惠氏有限责任公司 脑膜炎萘瑟氏菌rLP2086抗原的稳定制剂
AU2011300409B2 (en) 2010-09-10 2015-03-26 Wyeth Llc Non-lipidated variants of Neisseria meningitidis ORF2086 antigens
EP2654784B1 (en) 2010-12-22 2016-12-07 Wyeth LLC Stable immunogenic compositions of staphylococcus aureus antigens
DE102010056564A1 (de) 2010-12-30 2012-07-05 Clariant International Limited Hydroxylgruppen und Estergruppen tragende Polymere und Verfahren zu ihrer Herstellung
DE102010056565A1 (de) 2010-12-30 2012-07-05 Clariant International Ltd. Verfahren zur Modifizierung Hydroxylgruppen tragender Polymere
DE102010056566A1 (de) * 2010-12-30 2012-07-05 Clariant International Ltd. Kontinuierliches Verfahren zur Veresterung Säuregruppen tragender Polymere
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
MY198910A (en) 2012-03-09 2023-10-02 Pfizer Neisseria meningitidis compositions and methods thereof
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
JP6502262B2 (ja) 2012-12-20 2019-04-17 ファイザー・インク 糖複合化方法
WO2014136064A2 (en) 2013-03-08 2014-09-12 Pfizer Inc. Immunogenic fusion polypeptides
RU2662968C2 (ru) 2013-09-08 2018-07-31 Пфайзер Инк. Иммуногенная композиция против neisseria meningitidis (варианты)
EP3049106A1 (en) 2013-09-25 2016-08-03 Zoetis Services LLC Pcv2b divergent vaccine composition and methods of use
WO2016132294A1 (en) 2015-02-19 2016-08-25 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
MY182282A (en) 2015-05-04 2021-01-18 Pfizer Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
BR112018076015A8 (pt) * 2016-06-17 2022-06-28 Sanofi Pasteur Formulações imunogênicas compreendendo adjuvantes de polímero do ácido poliacrílico linear ou ramificado .
US10751402B2 (en) 2016-11-09 2020-08-25 Pfizer Inc. Immunogenic compositions and uses thereof
AU2018215585B2 (en) 2017-01-31 2022-03-17 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
US11433139B2 (en) 2018-03-16 2022-09-06 Zoetis Services Llc Peptide vaccines against interleukin-31
CN109134724A (zh) * 2018-07-24 2019-01-04 石家庄哈顿生物技术有限公司 一种动物疫苗用聚丙烯酸类聚合物佐剂的研制方法
WO2021059181A1 (en) 2019-09-27 2021-04-01 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
KR20230056727A (ko) 2020-08-26 2023-04-27 화이자 인코포레이티드 B군 스트렙토코쿠스 폴리사카라이드-단백질 접합체, 접합체를 생산하는 방법, 접합체를 포함하는 면역원성 조성물, 및 그의 용도
WO2026038177A1 (en) 2024-08-16 2026-02-19 Pfizer Inc. Immunogenic compositions and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567042A (en) * 1983-06-15 1986-01-28 American Home Products Corporation Inactivated canine coronavirus vaccine
ES2052685T3 (es) * 1987-03-17 1994-07-16 Akzo Nv Metodo para producir un adyuvante libre.
US5242686A (en) * 1990-11-07 1993-09-07 American Home Products Corporation Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
EP0532833A1 (en) * 1991-05-28 1993-03-24 Miles Inc. Vaccine for equine rhinopneumonitis
BE1008977A5 (fr) * 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.

Similar Documents

Publication Publication Date Title
JP2000502280A5 (https=)
JP2000514473A5 (https=)
JP2000501771A5 (https=)
JP2000501599A5 (https=)
JP2000501018A5 (https=)
JP2000501324A5 (https=)
JP2000517258A5 (https=)
JP2000502472A5 (https=)
JP2000501338A5 (https=)
JP2000501825A5 (https=)
JP2000500874A5 (https=)
JP2000502485A5 (https=)
JP2000502425A5 (https=)
JP2001507336A5 (https=)
JP2000502568A5 (https=)
JP2000501774A5 (https=)
JP2000516698A5 (https=)
JP2000500912A5 (https=)
JP2000502570A5 (https=)
JP2000501876A5 (https=)
JP2000501744A5 (https=)
JP2000501229A5 (https=)
JP2001500883A5 (https=)
JP2000502316A5 (https=)
JP2001504344A5 (https=)